Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
Ticker Information
Ticker
RNACCompany Name
CARTESIAN THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQCARTESIAN THERAPEUTICS INC - Price to Earnings Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
RNAC - P/E Historical data
| Date | Market Capitalization | Net Income Common Stock | Price to Earnings |
|---|---|---|---|
| 6/30/2025 | $ 274.06M | $ -38.89M | 0 |
| 3/31/2025 | $ 270.44M | $ -42.52M | 0 |
| 12/31/2024 | $ 430.32M | $ -77.42M | 0 |
| 9/30/2024 | $ 528.12M | $ -249.04M | 0 |
| 6/30/2024 | $ 275.19M | $ -233.86M | 0 |
| 3/31/2024 | $ 413.76M | $ -254.87M | 0 |
| 12/31/2023 | $ 104.25M | $ -219.71M | 0 |
| 9/30/2023 | $ 136.77M | $ -36.16M | 0 |
| 6/30/2023 | $ 171.84M | $ -35.05M | 0 |
| 3/31/2023 | $ 164.17M | $ -15.06M | 0 |
Key Performance Insights, Last 5 Years
- CARTESIAN THERAPEUTICS INC's latest trailing twelve months (TTM) P/E stands at 0.
- Over the past 5 years, CARTESIAN THERAPEUTICS INC's average P/E has been 7.39.
- The median P/E for CARTESIAN THERAPEUTICS INC during this period was 6.52
- CARTESIAN THERAPEUTICS INC reached its highest P/E over the past 5 years at 12.08.
- The lowest P/E recorded by CARTESIAN THERAPEUTICS INC in the same timeframe 4.44
Similar metrics to P/E:
- Earnings Yield - [Calculation] The Earnings Yield, also known as the inverse of the PE ratio [PE], expresses a company’s earnings [NetIncCmn] as a percentage of [MarketCap].
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
Definition of Price to Earnings
[Calculation] Measures a company’s [MarketCap] in relation to its Net Income [NetIncCmn]. A high P/E ratio indicates that investors anticipate greater future earnings growth compared to companies with a lower P/E.Market Cap / Net Inc. Cmn.
(=) P/E P/E for CARTESIAN THERAPEUTICS INC is calculated as follows: Market Cap [ $ 350.02M ] / Net Inc. Cmn. [ $ -68.32M ]
(=) P/E [ 0 ] RNAC - Price to Earnings, Last 5 years
4.44
Minimum
Mar 31, 2022
12.08
Maximum
Jun 30, 2022
7.39
Average
6.52
Median
P/E Benchmark AnalysisMarket
The chart above depicts the distribution of P/E for companies in the Total Stock Market. The average P/E of the companies is 22.54 with a standard deviation of 14.
The following table provides additional summary stats:
P/E in the Market:
| filtered constituents | 2.08K |
|---|---|
| min | 0.13 |
| max | 70.48 |
| average | 22.54 |
| median | 18.89 |
| std | 14 |